New products for managing inhibitors to coagulation factors: a focus on recombinant factor VIIa concentrate.
A very good review of inhibitors to coagulation factors, in congenital or acquired hemophilia, that covers the incidence, pathogenesis, treatment strategies (including different alternatives to human factors), and induction of […]